ANGELA CARLSON: Open Payments
NPI 1598088858 · LINCOLN CITY, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $63 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $102 |
| Lundbeck LLC | 3 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $21 |
Products named: REXULTI, INGREZZA, CAPLYTA, Auvelity, COBENFY, FANAPT, ARISTADA.
Industry payments across OR — which companies pay providers there.
